Integrated in vitro and in silico assessment reveals therapeutic potentials of Ruellia patula leaves, suggesting a source of multifunctional agents.
Ruellia patula leaf extracts were analyzed for phytochemical composition and therapeutic activity using combined in vitro and in silico methods. FTIR and GC-MS identified abundant flavonoids, polyphenols, terpenoids, and steroids. The ethanolic extract exhibited potent antioxidant effects, with IC₅₀ values of 48.79 µg/mL (DPPH) and 58.53 µg/mL (H₂O₂), and showed notable anti-inflammatory activity in protein denaturation and membrane stabilization assays. Significant cytotoxicity (72.07% yeast cell inhibition) and antimitotic activity (mitotic index reduced to 37.43%; root growth inhibition up to 85.62% at 1000 µg/mL) were observed. The plant extract exhibited pronounced antibacterial effects, especially against S. aureus. Docking studies of key compounds, stigmasterol and benzo[h]quinoline derivatives, revealed strong binding affinities to targets including myeloperoxidase, cyclooxygenase-1, tubulin, and penicillin-binding protein 2a. These findings validate the traditional uses of R. patula and highlight its promise as a source of multifunctional therapeutic agents.
No takes yet. Share an insight, caveat, or question.
Govindan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: